Diet and Nutritional Interventions with the Special Role of Myo-Inositol in Gestational Diabetes Mellitus Management. An Evidence-Based Critical Appraisal

Reyes-Munoz E., Di Guardo F., Ciebiera M., Kahramanoglu I., Sathya-palan T., Lin L., ...Daha Fazla

CURRENT PHARMACEUTICAL DESIGN, cilt.25, sa.22, ss.2467-2473, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 25 Sayı: 22
  • Basım Tarihi: 2019
  • Doi Numarası: 10.2174/1381612825666190722155512
  • Dergi Adı: CURRENT PHARMACEUTICAL DESIGN
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2467-2473
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: Gestational Diabetes Mellitus (GDM), defined as glucose intolerance with onset or first recognition during pregnancy, represents one of the most common maternal-fetal complications during pregnancy and it is associated with poor perinatal outcomes. To date, GDM is a rising condition over the last decades coinciding with the ongoing epidemic of obesity and Type 2 Diabetes Mellitus (T2DM).